DE69508890T2 - Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen - Google Patents

Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen

Info

Publication number
DE69508890T2
DE69508890T2 DE69508890T DE69508890T DE69508890T2 DE 69508890 T2 DE69508890 T2 DE 69508890T2 DE 69508890 T DE69508890 T DE 69508890T DE 69508890 T DE69508890 T DE 69508890T DE 69508890 T2 DE69508890 T2 DE 69508890T2
Authority
DE
Germany
Prior art keywords
decapeptide
contg
leu
drugs
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69508890T
Other languages
English (en)
Other versions
DE69508890D1 (de
Inventor
Laurent Miclo
Emanuel Perrin
Alain Driou
Jean-Francois Boudier
Catherine Iung
Guy Linden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ingredia SA
Original Assignee
Laitiere Dartois et des Flandres SCA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laitiere Dartois et des Flandres SCA filed Critical Laitiere Dartois et des Flandres SCA
Application granted granted Critical
Publication of DE69508890D1 publication Critical patent/DE69508890D1/de
Publication of DE69508890T2 publication Critical patent/DE69508890T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DE69508890T 1994-11-30 1995-11-30 Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen Expired - Lifetime DE69508890T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414362A FR2727315A1 (fr) 1994-11-30 1994-11-30 Utilisation d'un decapeptide a activite de type benzodiazepine pour la preparation de medicaments et de complements alimentaires

Publications (2)

Publication Number Publication Date
DE69508890D1 DE69508890D1 (de) 1999-05-12
DE69508890T2 true DE69508890T2 (de) 1999-10-07

Family

ID=9469315

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69508890T Expired - Lifetime DE69508890T2 (de) 1994-11-30 1995-11-30 Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen

Country Status (10)

Country Link
US (1) US5846939A (de)
EP (1) EP0714910B1 (de)
JP (1) JP3973244B2 (de)
AT (1) ATE178615T1 (de)
DE (1) DE69508890T2 (de)
DK (1) DK0714910T3 (de)
ES (1) ES2135023T3 (de)
FR (1) FR2727315A1 (de)
GR (1) GR3030650T3 (de)
SI (1) SI0714910T1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465432B1 (en) * 2000-08-28 2002-10-15 Kraft Food Holdings, Inc. Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
EP1275308A1 (de) * 2001-07-13 2003-01-15 The Procter & Gamble Company Lebensmittelzusammenstellung mit stresslinderenden Eigenschaften für Säugetiere
NL1032322C2 (nl) * 2006-08-15 2008-02-18 Friesland Brands Bv Slaapmelk.
FR2909879B1 (fr) * 2006-12-13 2009-03-13 Lorraine Inst Nat Polytech Utilisation d'un heptapeptide a activite anxiolytique pour la preparation de medicaments et de complements alimentaires
FR2932090B1 (fr) * 2008-06-06 2012-09-14 Lorraine Inst Nat Polytech Compositions anxiolytiques comprenant des peptides derives de la caseine alpha s1
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
JP2019514977A (ja) 2016-05-06 2019-06-06 フィジシャンズ シール,エルエルシー バレリアン組成物及び関連方法
US10980269B2 (en) * 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
JPH06239888A (ja) * 1993-02-18 1994-08-30 Kanebo Ltd 新規ペプチド及び鎮静剤並びに精神安定用食品

Also Published As

Publication number Publication date
US5846939A (en) 1998-12-08
EP0714910B1 (de) 1999-04-07
SI0714910T1 (en) 1999-10-31
EP0714910A1 (de) 1996-06-05
FR2727315A1 (fr) 1996-05-31
GR3030650T3 (en) 1999-10-29
FR2727315B1 (de) 1997-02-14
DK0714910T3 (da) 1999-10-18
DE69508890D1 (de) 1999-05-12
ES2135023T3 (es) 1999-10-16
JP3973244B2 (ja) 2007-09-12
ATE178615T1 (de) 1999-04-15
JPH08268903A (ja) 1996-10-15

Similar Documents

Publication Publication Date Title
ES2132158T3 (es) Producto enterico nutritivo.
EP0339656A3 (en) Lactalbumin as food supplement
CA2221455A1 (en) Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
BR0115557A (pt) Material de semente oleaginosa modificada e método para produzir o mesmo
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
DE3778699D1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
DE69831658D1 (de) Produkte mit hohem beta-conglycinin-gehalt und ihre verwendung
DE68924429T2 (de) Diät zur besserem Ueberleben von Kranken mit Sepsis.
DK0626176T3 (da) Næringsmiddel til personer, som undergår stråleterapi eller kemoterapi
DE69508890T2 (de) Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen
DE69910990D1 (de) Nahrungsmittel mit biotin und anderen b-vitaminen
ATE285685T1 (de) Zusatz zu einem diätetischen energieträger, verwendung eines proteinhydrolysates zur herstellung eines energieträgers und ein energieträger, der einen solchen zusatz enthält
WO1988003150A3 (fr) Preparations aminoacides contenant des peptides de n,n'-bis-l-aminoacide-l-cystine et destinees a l'administration orale et parenterale
DE69302375T2 (de) Kosmetische zusammensetzung zur erhaltung der frisur enthaltend ein milchprotein und/oder ein milchproteinhydrolysate und ein hydrolysate
ATE329500T1 (de) Verwendung eines organspezifischen ernährungmittels
DE68907170T2 (de) Proteinhaltige zusammensetzung.
ES2164876T3 (es) Procedimiento para la fabricacion de alimentos dieteticos para lactantes y niños prematuros y alimentos dieteticos.
ES2067058T3 (es) Tratamiento de carnes.
IT1261172B (it) Composizione per l'alimentazione di soggetti, neonati ed adulti che non tollerano le proteine del latte vaccino e della soia e/o il lattosio.
IT8920225A0 (it) Integratori dietetici, in particolare per condizioni di accresciuto catabolismo proteico.
IT8786215A0 (it) Prodotto alimentare dietetico yogurt dessert all'uovo ed affini, con procedimento di conservazione edi produzione industriale
ITRM910310A0 (it) Procedimento per la confezione finale di insaccati in genere, particolarmente salami, e prodotto relativo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INGREDIA, ARRAS, FR